Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao Quan

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
BMC Cancer|February 8, 2013
Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell linesCaroline Gest, Ulrich Joimel, Limin Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodelingMing Hu, Xiao-Jian Sun, Yuan-Liang Zhang, et al.
Chinese Medical Journal|February 5, 2024
Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter studyChao Quan, Hongyu Zhou, Huan Yang, et al.
Neurobiology of Disease|November 2, 2018
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease modelsAndreas Weihofen, YuTing Liu, Joseph W Arndt, et al.
The Journal of Pathology|September 13, 2014
Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cellsWenjing Sun, Chao Quan, Yun Huang, et al.
Nature Communications|November 6, 2024
AS160 is a lipid-responsive regulator of cardiac Ca<sup>2+</sup> homeostasis by controlling lysophosphatidylinositol metabolism and signalingShu Su, Chao Quan, Qiaoli Chen, et al.
Journal of Neurology|July 3, 2024
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysisSimon Arnett, Sin Hong Chew, Unnah Leitner, et al.
Therapeutic Advances in Neurological Disorders|April 15, 2024
Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in ChinaJun Guo, Jiayong Wu, Lihua Wang, et al.
Frontiers in Neurology|August 22, 2022
Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibodyLiang Wang, Lei Du, Qinying Li, et al.
Frontiers in Immunology|April 18, 2022
Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction ModelsLiang Wang, Lei Du, Qinying Li, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
BMC Cancer|February 8, 2013
Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell linesCaroline Gest, Ulrich Joimel, Limin Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodelingMing Hu, Xiao-Jian Sun, Yuan-Liang Zhang, et al.
Chinese Medical Journal|February 5, 2024
Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter studyChao Quan, Hongyu Zhou, Huan Yang, et al.
Neurobiology of Disease|November 2, 2018
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease modelsAndreas Weihofen, YuTing Liu, Joseph W Arndt, et al.
The Journal of Pathology|September 13, 2014
Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cellsWenjing Sun, Chao Quan, Yun Huang, et al.
Nature Communications|November 6, 2024
AS160 is a lipid-responsive regulator of cardiac Ca<sup>2+</sup> homeostasis by controlling lysophosphatidylinositol metabolism and signalingShu Su, Chao Quan, Qiaoli Chen, et al.
Journal of Neurology|July 3, 2024
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysisSimon Arnett, Sin Hong Chew, Unnah Leitner, et al.
Therapeutic Advances in Neurological Disorders|April 15, 2024
Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in ChinaJun Guo, Jiayong Wu, Lihua Wang, et al.
Frontiers in Neurology|August 22, 2022
Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibodyLiang Wang, Lei Du, Qinying Li, et al.
Frontiers in Immunology|April 18, 2022
Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction ModelsLiang Wang, Lei Du, Qinying Li, et al.
Pageof 21